Nomura Asset Management
ONCE

Nomura Asset Management’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Nomura Asset Management’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-7,000
Closed -$514K – 955
2018
Q4 		$274K Hold
7,000
– – ﹤0.01% 866
2018
Q3 		$382K Hold
7,000
– – ﹤0.01% 862
2018
Q2 		$579K Hold
7,000
– – 0.01% 836
2018
Q1 		$466K Hold
7,000
– – 0.01% 848
2017
Q4 		$360K Buy
+7,000
New +$503K ﹤0.01% 856

Other funds holding ONCE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Nomura Asset Management's ONCE Position: Q1 2019 in Review

Nomura Asset Management sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q1 2019, closing a stake of 7,000 shares — an estimated $514K sold.

Nomura Asset Management first reported a position in ONCE in Q4 2017 and held it in 5 quarters. The position peaked at $579K in Q2 2018. 199 funds tracked by Wall St. Rank hold ONCE as of Q1 2019.

  • Nomura Asset Management reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • Nomura Asset Management sold 7,000 Spark Therapeutics, Inc. Common Stock shares in Q1 2019, an estimated $514K.
  • Nomura Asset Management first reported a position in Spark Therapeutics, Inc. Common Stock in Q4 2017 and held it in 5 quarters.
  • Nomura Asset Management's Spark Therapeutics, Inc. Common Stock position peaked at $579K in Q2 2018.
  • 199 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q1 2019.

Based on Nomura Asset Management's 13F filing for Q1 2019, filed 10 May 2019.